Bacchic Medicine

Bacchic Medicine
Author: Harry W. Paul
Publisher: BRILL
Total Pages: 321
Release: 2016-09-27
Genre: Medical
ISBN: 9004333428

Wine has always been a part of popular medicine. Bacchic Medicine analyses the historical role of wine in the treatment of disease and preservation of health. The Hippocratic texts gave wine therapy a canonical statement over two millennia ago; but the nineteenth century was the golden age of alcohol and wine therapy. The Germans and the British gave us early canons of wine therapy and, heavily endowed with wine cultural capital, the French followed. But like all therapies, alcohol and wine therapies were not without danger and some of the ‘iatrogenic’ tales are still with us. In the twentieth century, many doctors rallied to the defence of wine both as a substitute for more dangerous alcoholic drinks and as an efficacious medicament, with an impressive case for the efficacy of wine in fighting bacteria, heart disease and cancer. New science based on animal models and ionic theory fortified their arguments. According to the controversial ‘French Paradox’, wine drinking makes it possible for a population to enjoy a high fat diet yet suffer little. Bacchic Medicine also discusses the contemporary debate over the role of alcohol and wine in preventive medicine.

That High Design Of Purest Gold: A Critical History Of The Pharmaceutical Industry, 1880-2020

That High Design Of Purest Gold: A Critical History Of The Pharmaceutical Industry, 1880-2020
Author: Graham Dutfield
Publisher: World Scientific
Total Pages: 525
Release: 2020-11-11
Genre: Medical
ISBN: 9811222495

This book is a history of medicines and the commercial actors that make and sell them, covering the 140 years since the modern pharmaceutical industry came into being. It is written in a lively and accessible way, aiming at a general audience that combines historical narrative with fascinating case studies on drug discovery and commercialization, from the rat poison that became warfarin, to a cardiovascular treatment that was turned into Viagra. In a non-partisan way it also examines some of the less noble manifestations of corporate behavior, concluding with an agenda for reform.It is hard to think of anything nobler than to bring to the world a medicine that saves lives. And over 140 years of history, the pharmaceutical industry has produced a range of remarkable products, albeit typically with external scientific and financial support. Making medicines is a very big and profit-driven business, and the industry does not always make the right products for the right people, or at the right prices.The industry wields immense power over lives and economies. How has it risen to this position of dominance? Are the interests of the industry and the public in balance? What should we admire about the industry? What should we criticise and seek to change? The importance of this book lies in the fact that we are all stakeholders in this industry whether or not we own shares, so we all need answers to these questions.Related Link(s)

The Search for Anti-Inflammatory Drugs

The Search for Anti-Inflammatory Drugs
Author: Vincent J. Merluzzi
Publisher: Springer Science & Business Media
Total Pages: 310
Release: 2012-12-06
Genre: Medical
ISBN: 146159846X

Perspectives on Anti-Inflammatory Drugs Inflammation is a very complicated process of interrelated events and cas cades that does not allow for an easily defined, focused attack for drug discovery. It is evident from years of research and development that certain classes of compounds (e.g., NSAIDs, steroids, and so on) have had a meas ure of success in alleviating pain and even dampening cellularlhormonal mechanisms involved in the process. Clear, mechanism-related therapies (e.g., for arthritis) and targeted drugs (e.g., for transplantation) have not been available in the past and, in reality, research in inflammation has re lied on more phenomenological approaches for resolving symptoms or on blatant cytoreductive approaches in cases like organ transplantation. In the last decade, approaches that have revealed novel cellular pathways in which intervention is possible for lymphocyte regulation (for example, cyclosporine and FK506) and small molecular weight mediators (e.g., leu kotriene inhibitors) are now either standard therapy or will be in a short time. These latter approaches have been the result of research from the 1970s up to the present.